> Chutes & Ladders: NitroMed CEO Michael Loberg and CFO Lawrence Block resigned today. No reason for their sudden departure was given. The company's stock has slid 44 percent this year. Report [1]
> Novavax, which is developing avian and seasonal flu vaccines, is selling $38 million in stock. Report [2]
> Anaclim, an Indianapolis-based clinical trial firm launched by two Lilly veterans, intends to do a better job recruiting minorities for drug studies. Article [3]
> Codexis has signed a research collaboration pact with Schering-Plough. Release [4]
And Finally… A debate has developed over the aggressive use of drugs to deal early on with schizophrenia. Article [5]
Links:
[1] http://www.businessweek.com/ap/financialnews/D8GFVLO80.htm?campaign_id=apn_home_down&chan=db
[2] http://www.businessweek.com/ap/financialnews/D8GFVOOG0.htm?campaign_id=apn_home_down&chan=db
[3] http://www.indystar.com/apps/pbcs.dll/article?AID=/20060320/BUSINESS/603200335/1003
[4] http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-21-2006/0004323971&EDATE=
[5] http://www.nytimes.com/2006/03/21/health/psychology/21schiz.html